Empowering Patient Perspectives in Influenza Research and Management: A Comprehensive Review of Patient-Reported Outcomes
Clinical Scorecard: Empowering Patient Perspectives in Influenza Research and Management: A Comprehensive Review of Patient-Reported Outcomes
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Acute respiratory infectious disease with rapid transmission and significant morbidity, including exacerbation of chronic conditions. |
| Target Population | |
| Care Setting | |
Key Highlights
- Influenza causes 294,000 to 518,000 deaths globally each year.
- Patient-reported outcomes (PROs) capture patients' lived experiences and health status.
- Generic PRO instruments may underestimate disease-specific impacts.
- Targeted PRO measures can provide detailed evaluations of influenza's impact.
- Patient experiences of influenza vary significantly among individuals.
- Influenza imposes considerable economic costs due to workplace absenteeism.
Guideline-Based Recommendations
Diagnosis
Management
- Incorporate PRO measures in clinical trials and observational studies.
- Utilize disease-specific PRO instruments such as the Influenza Impact Wellbeing Scale.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
PROs can inform personalized care and public health decisions, guiding specific treatment adjustments.
Clinical Best Practices
- Implement PRO measures in clinical trials for more patient-centered outcomes.
- Use disease-specific PRO instruments to capture the true impact of influenza.
- Regularly update PRO measures based on emerging research findings.
Related Resources & Content
